Proteomic analysis of rat brain mitochondria following exposure to dopamine quinone: Implications for Parkinson disease

Neurobiology of Disease

Volumn 29, Issue 3, 2008, Pages 477-489

  Van Laar, Victor S ^a   Dukes, April A ^a   Cascio, Michael ^b   Hastings, Teresa G ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

2 D DIGE; Dopamine; Dopamine quinone; Mitochondria; Mitochondrial creatine kinase; Mitofilin; Parkinson disease; PC12 cells; Proteomics

Indexed keywords

DOPAMINE; FLUORESCENT DYE; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL CREATINE KINASE; MITOFILIN; MORTALIN; PROTEIN; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CELL STRAIN; DRUG EXPOSURE; GEL ELECTROPHORESIS; IN VITRO STUDY; MALE; NONHUMAN; OXIDATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEOMICS; RAT; WESTERN BLOTTING;

ANIMALS; BRAIN; DOPAMINE; MALE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OXIDATIVE STRESS; PARKINSON DISEASE; PC12 CELLS; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 39249083911     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2007.11.007     Document Type: Article

References (64)

1. Beal M.F. Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann. N.Y. Acad. Sci. 991 (2003) 120-131
2. Benit P., Chretien D., Kadhom N., de Lonlay-Debeney P., Cormier-Daire V., Cabral A., Peudenier S., Rustin P., Munnich A., and Rotig A. Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. Am. J. Hum. Genet. 68 (2001) 1344-1352
3. Berman S.B., and Hastings T.G. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J. Neurochem. 73 (1999) 1127-1137
4. Berman S.B., Watkins S.C., and Hastings T.G. Quantitative biochemical and ultrastructural comparison of mitochondrial permeability transition in isolated brain and liver mitochondria: evidence for reduced sensitivity of brain mitochondria. Exp. Neurol. 164 (2000) 415-425
5. Betarbet R., Sherer T.B., Di Monte D.A., and Greenamyre J.T. Mechanistic approaches to Parkinson's disease pathogenesis. Brain Pathol. 12 (2002) 499-510
6. Beutner G., Ruck A., Riede B., and Brdiczka D. Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochim. Biophys. Acta 1368 (1998) 7-18
7. Blandini F., Nappi G., and Greenamyre J.T. Quantitative study of mitochondrial complex I in platelets of parkinsonian patients. Mov. Disord. 13 (1998) 11-15
8. Bota D.A., and Davies K.J. Protein degradation in mitochondria: implications for oxidative stress, aging and disease: a novel etiological classification of mitochondrial proteolytic disorders. Mitochondrion 1 (2001) 33-49
9. Bota D.A., and Davies K.J. Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat. Cell Biol. 4 (2002) 674-680
10. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
11. Brdiczka D.G., Zorov D.B., and Sheu S.S. Mitochondrial contact sites: their role in energy metabolism and apoptosis. Biochim. Biophys. Acta 1762 (2006) 148-163
12. Bugiani M., Invernizzi F., Alberio S., Briem E., Lamantea E., Carrara F., Moroni I., Farina L., Spada M., Donati M.A.., Uziel G., and Zeviani M. Clinical and molecular findings in children with complex I deficiency. Biochim. Biophys. Acta 1659 (2004) 136-147
13. Bulteau A.L., Szweda L.I., and Friguet B. Mitochondrial protein oxidation and degradation in response to oxidative stress and aging. Exp. Gerontol. 41 (2006) 653-657
14. Chan H.L., Gharbi S., Gaffney P.R., Cramer R., Waterfield M.D., and Timms J.F. Proteomic analysis of redox- and ErbB2-dependent changes in mammary luminal epithelial cells using cysteine- and lysine-labelling two-dimensional difference gel electrophoresis. Proteomics 5 (2005) 2908-2926
15. Cheng E.H., Sheiko T.V., Fisher J.K., Craigen W.J., and Korsmeyer S.J. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 301 (2003) 513-517
16. Cohen G., Farooqui R., and Kesler N. Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4890-4894
17. Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 (2003) 889-909
18. Dolder M., Wendt S., and Wallimann T. Mitochondrial creatine kinase in contact sites: interaction with porin and adenine nucleotide translocase, role in permeability transition and sensitivity to oxidative damage. Biol. Signals Recept. 10 (2001) 93-111
19. Fornstedt B., Brun A., Rosengren E., and Carlsson A. The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra. J. Neural Transm., Parkinson's Dis. Dement. Sect. 1 (1989) 279-295
20. Geissler A., Rassow J., Pfanner N., and Voos W. Mitochondrial import driving forces: enhanced trapping by matrix Hsp70 stimulates translocation and reduces the membrane potential dependence of loosely folded preproteins. Mol. Cell. Biol. 21 (2001) 7097-7104
21. Gluck M., Ehrhart J., Jayatilleke E., and Zeevalk G.D. Inhibition of brain mitochondrial respiration by dopamine: involvement of H(2)O(2) and hydroxyl radicals but not glutathione-protein-mixed disulfides. J. Neurochem. 82 (2002) 66-74
22. Graham D.G., Tiffany S.M., Bell W.R., and Gutknecht W.F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14 (1978) 644-653
23. Greenamyre J.T., and Hastings T.G. Biomedicine. Parkinson's-divergent causes, convergent mechanisms. Science 304 (2004) 1120-1122
24. Hastings T.G., Lewis D.A., and Zigmond M.J. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 1956-1961
25. Hurd T.R., Prime T.A., Harbour M.E., Lilley K.S., and Murphy M.P. Detection of reactive oxygen species-sensitive thiol proteins by redox difference gel electrophoresis: implications for mitochondrial redox signaling. J. Biol. Chem. 282 (2007) 22040-22051
26. Iuso A., Scacco S., Piccoli C., Bellomo F., Petruzzella V., Trentadue R., Minuto M., Ripoli M., Capitanio N., Zeviani M., and Papa S. Dysfunctions of cellular oxidative metabolism in patients with mutations in the NDUFS1 and NDUFS4 genes of complex I. J. Biol. Chem. 281 (2006) 10374-10380
27. Janetzky B., Hauck S., Youdim M.B., Riederer P., Jellinger K., Pantucek F., Zochling R., Boissl K.W., and Reichmann H. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci. Lett. 169 (1994) 126-128
28. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 53 Suppl 3 (2003) S26-S36 (discussion S36-8)
29. Jin J., Meredith G.E., Chen L., Zhou Y., Xu J., Shie F.S., Lockhart P., and Zhang J. Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Brain Res. Mol. Brain Res. 134 (2005) 119-138
30. Jin J., Hulette C., Wang Y., Zhang T., Pan C., Wadhwa R., and Zhang J. Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease. Mol. Cell. Proteomics. 5 (2006) 1193-1204
31. Jin J., Li G.J., Davis J., Zhu D., Wang Y., Pan C., and Zhang J. Identification of novel proteins interacting with both α-synuclein and DJ-1. Mol. Cell. Proteomics. 6 (2007) 845-859
32. John G.B., Shang Y., Li L., Renken C., Mannella C.A., Selker J.M., Rangell L., Bennett M.J., and Zha J. The mitochondrial inner membrane protein mitofilin controls cristae morphology. Mol. Biol. Cell 16 (2005) 1543-1554
33. Jones D.C., Gunasekar P.G., Borowitz J.L., and Isom G.E. Dopamine-induced apoptosis is mediated by oxidative stress and is enhanced by cyanide in differentiated PC12 cells. J. Neurochem. 74 (2000) 2296-2304
34. Kim S.H., Vlkolinsky R., Cairns N., Fountoulakis M., and Lubec G. The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease. Life Sci. 68 (2001) 2741-2750
35. Koshimura K., Tanaka J., Murakami Y., and Kato Y. Effects of dopamine and l-DOPA on survival of PC12 cells. J. Neurosci. Res. 62 (2000) 112-119
36. Lenaz G., Bovina C., D'Aurelio M., Fato R., Formiggini G., Genova M.L., Giuliano G., Merlo Pich M., Paolucci U., Parenti Castelli G., and Ventura B. Role of mitochondria in oxidative stress and aging. Ann. N.Y. Acad. Sci. 959 (2002) 199-213
37. Lenz H., Schmidt M., Welge V., Kueper T., Schlattner U., Wallimann T., Elsasser H.P., Wittern K.P., Wenck H., Staeb F., and Blatt T. Inhibition of cytosolic and mitochondrial creatine kinase by siRNA in HaCaT- and HeLaS3-cells affects cell viability and mitochondrial morphology. Mol. Cell. Biochem. 306 (2007) 153-162
38. Li H.M., Niki T., Taira T., Iguchi-Ariga S.M., and Ariga H. Association of DJ-1 with chaperones and enhanced association and colocalization with mitochondrial Hsp70 by oxidative stress. Free Radic. Res. 39 (2005) 1091-1099
39. Magi B., Ettorre A., Liberatori S., Bini L., Andreassi M., Frosali S., Neri P., Pallini V., and Di Stefano A. Selectivity of protein carbonylation in the apoptotic response to oxidative stress associated with photodynamic therapy: a cell biochemical and proteomic investigation. Cell Death Differ. 11 (2004) 842-852
40. Myung J.K., Gulesserian T., Fountoulakis M., and Lubec G. Deranged hypothetical proteins Rik protein, Nit protein 2 and mitochondrial inner membrane protein, mitofilin, in fetal Down syndrome brain. Cell. Mol. Biol. (Noisy-le-grand). 49 (2003) 739-746
41. Ogawa N., Asanuma M., Miyazaki I., Diaz-Corrales F.J., and Miyoshi K. l-DOPA treatment from the viewpoint of neuroprotection. Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease. J. Neurol. 252 Suppl 4 (2005) IV23-IV31
42. Orth M., and Schapira A.H. Mitochondrial involvement in Parkinson's disease. Neurochem. Int. 40 (2002) 533-541
43. Palacino J.J., Sagi D., Goldberg M.S., Krauss S., Motz C., Wacker M., Klose J., and Shen J. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem. 279 (2004) 18614-18622
44. Pallanck L., and Greenamyre J.T. Neurodegenerative disease: pink, parkin and the brain. Nature 441 (2006) 1058
45. Periquet M., Corti O., Jacquier S., and Brice A. Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function. J. Neurochem. 95 (2005) 1259-1276
46. Poon H.F., Frasier M., Shreve N., Calabrese V., Wolozin B., and Butterfield D.A. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice-a model of familial Parkinson's disease. Neurobiol. Dis. 18 (2005) 492-498
47. Rabinovic A.D., Lewis D.A., and Hastings T.G. Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine. Neuroscience 101 (2000) 67-76
48. Rosenthal R.E., Hamud F., Fiskum G., Varghese P.J., and Sharpe S. Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine. J. Cereb. Blood Flow Metab. 7 (1987) 752-758
49. Samii A., Nutt J.G., and Ransom B.R. Parkinson's disease. Lancet 363 (2004) 1783-1793
50. Schapira A.H., Cooper J.M., Dexter D., Clark J.B., Jenner P., and Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54 (1990) 823-827
51. Schlattner U., Forstner M., Eder M., Stachowiak O., Fritz-Wolf K., and Wallimann T. Functional aspects of the X-ray structure of mitochondrial creatine kinase: a molecular physiology approach. Mol. Cell. Biochem. 184 (1998) 125-140
52. Scott C.R. The genetic tyrosinemias. Am. J. Med. Genet. C Semin. Med. Genet. 142 (2006) 121-126
53. Shaw J., Rowlinson R., Nickson J., Stone T., Sweet A., Williams K., and Tonge R. Evaluation of saturation labelling two-dimensional difference gel electrophoresis fluorescent dyes. Proteomics 3 (2003) 1181-1195
54. Shen X.M., Li H., and Dryhurst G. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the alpha-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease. J. Neural Transm. 107 (2000) 959-978
55. Shoffner J.M., Watts R.L., Juncos J.L., Torroni A., and Wallace D.C. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann. Neurol. 30 (1991) 332-339
56. Shoshan-Barmatz V., Israelson A., Brdiczka D., and Sheu S.S. The voltage-dependent anion channel (VDAC): function in intracellular signalling, cell life and cell death. Curr. Pharm. Des. 12 (2006) 2249-2270
57. Speer O., Back N., Buerklen T., Brdiczka D., Koretsky A., Wallimann T., and Eriksson O. Octameric mitochondrial creatine kinase induces and stabilizes contact sites between the inner and outer membrane. Biochem. J. 385 (2005) 445-450
58. Spencer J.P., Jenner P., Daniel S.E., Lees A.J., Marsden D.C., and Halliwell B. Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species. J. Neurochem. 71 (1998) 2112-2122
59. Stokes A.H., Hastings T.G., and Vrana K.E. Cytotoxic and genotoxic potential of dopamine. J. Neurosci. Res. 55 (1999) 659-665
60. Suh S.K., Hood B.L., Kim B.J., Conrads T.P., Veenstra T.D., and Song B.J. Identification of oxidized mitochondrial proteins in alcohol-exposed human hepatoma cells and mouse liver. Proteomics 4 (2004) 3401-3412
61. Taylor S.W., Fahy E., Murray J., Capaldi R.A., and Ghosh S.S. Oxidative post-translational modification of tryptophan residues in cardiac mitochondrial proteins. J. Biol. Chem. 278 (2003) 19587-19590
62. Vyssokikh M.Y., and Brdiczka D. The function of complexes between the outer mitochondrial membrane pore (VDAC) and the adenine nucleotide translocase in regulation of energy metabolism and apoptosis. Acta Biochim. Pol. 50 (2003) 389-404
63. Wendt S., Schlattner U., and Wallimann T. Differential effects of peroxynitrite on human mitochondrial creatine kinase isoenzymes. Inactivation, octamer destabilization, and identification of involved residues. J. Biol. Chem. 278 (2003) 1125-1130
64. Xie J., Marusich M.F., Souda P., Whitelegge J., and Capaldi R.A. The mitochondrial inner membrane protein Mitofilin exists as a complex with SAM50, metaxins 1 and 2, coiled-coil - helix coiled-coil - helix domain-containing protein 3 and 6 and DnaJC11. FEBS Lett. 581 (2007) 3545-3549